Marc Dooms
Impact in
- Dermatology top 5%
- Contact Dermatitis and Allergies
-
- Pharmaceutical studies and practices
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 20
- Pharmaceutical Economics and Policy 15
-
- Pharmaceutical studies and practices 16
- Co-authors
- Steven Simoens (16 shared papers)David Cassiman (9 shared papers)Eline Picavet (8 shared papers)A. Dooms‐Goossens (14 shared papers)H. Degreef (10 shared papers)Maria Helena Catelli de Carvalho (1 shared paper)Isabelle Huys (5 shared papers)Eline van Overbeeke (2 shared papers)
- Journals
- Contact Dermatitis (12 papers)Frontiers in Pharmacology (7 papers)Orphanet Journal of Rare Diseases (7 papers)Value in Health (3 papers)The Lancet Global Health (1 paper)
- Partner nations
- BelgiumNetherlandsFrance
In The Last Decade
Marc Dooms
49 papers receiving 701 citations
Peers
Comparison fields: 5 of 97
- Dermatology 154
- Pediatrics, Perinatology and Child Health 119
- Economics and Econometrics 194
- Immunology and Allergy 34
- Genetics 124
Countries citing papers authored by Marc Dooms
This map shows the geographic impact of Marc Dooms's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Dooms with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Dooms more than expected).
Fields of papers citing papers by Marc Dooms
This network shows the impact of papers produced by Marc Dooms. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Dooms. The network helps show where Marc Dooms may publish in the future.
Co-authors
The 25 scholars most cited alongside Marc Dooms, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 94 | |
| 2 | 2018 | 51 | |
| 3 | 2012 | 49 | |
| 4 | 2011 | 45 | |
| 5 | 1986 | 40 | |
| 6 | 2009 | 35 | |
| 7 | 2021 | 35 | |
| 8 | 2021 | 28 | |
| 9 | 2011 | 27 | |
| 10 | 2023 | 22 | |
| 11 | 2012 | 19 | |
| 12 | 2017 | 18 | |
| 13 | 2019 | 18 | |
| 14 | 2010 | 17 | |
| 15 | 1986 | 16 | |
| 16 | 2024 | 15 | |
| 17 | 1980 | 14 | |
| 18 | 1979 | 14 | |
| 19 | 2018 | 14 | |
| 20 | 2011 | 14 |
About Marc Dooms
Marc Dooms is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health, Dermatology, Genetics and Management of Technology and Innovation, having authored 53 papers that have together received 737 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (20 papers), Pharmaceutical studies and practices (16 papers), Pharmaceutical Economics and Policy (15 papers), Contact Dermatitis and Allergies (14 papers), Genomics and Rare Diseases (8 papers), Intellectual Property and Patents (4 papers), BRCA gene mutations in cancer (3 papers) and Neurogenetic and Muscular Disorders Research (3 papers). The work is most often cited by research in Dermatology (154 citations), Pediatrics, Perinatology and Child Health (119 citations), Economics and Econometrics (194 citations), Immunology and Allergy (34 citations) and Genetics (124 citations). Marc Dooms has collaborated with scholars based in Belgium, Netherlands and France. Frequent co-authors include Steven Simoens, David Cassiman, Eline Picavet, A. Dooms‐Goossens, H. Degreef, Maria Helena Catelli de Carvalho, Isabelle Huys, Eline van Overbeeke, Yann Le Cam and Annemieke Aartsma‐Rus. Their work appears in journals such as Contact Dermatitis, Frontiers in Pharmacology, Orphanet Journal of Rare Diseases, Value in Health and The Lancet Global Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.